Patent · US Active

Crystalline ligand

US10077281B2 · kind B2 · utility

0Cited by
3References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 15, 2016
Grant dateSep 18, 2018
Priority date—
Expiry dateJun 15, 2036

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB01J2235/15
  • WIPO fieldChemical engineering
  • WIPO sectorChemistry

Abstract

A ligand crystal structure of 6,6′-[[3,3′,5,5′-tetrakis(1,1-dimethylethyl)-[1,1′-biphenyl]-2,2′-diyl]bis(oxy)]bisdibenzo[d,f][1,3,2]-dioxaphosphepin. Formule (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.